Download PDF April 9, 2014 at 3:09 AM Michael Chopp, Ph.D., scientific director of the Henry Ford Neuroscience Institute at Henry Ford Hospital, won the 2014 Abraham White Distinguished Science Award for his discovery of the role of a protein in the treatment of brain injuries and neurodegenerative diseases. The award, given by George Washington […]Continue Reading ...
Download PDF February 24, 2017 at 2:02 AM Proteins do most of the work inside the human body, supporting the structure, function, regulation, and repair of organs, tissues and cells. Proteins are synthesized as extended chains of amino acids that must fold into intricate three-dimensional shapes to perform their work. However, protein folding is a […]Continue Reading ...
Download PDF December 15, 2015 at 8:10 AM Kitov Pharmaceuticals (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug […]Continue Reading ...
Download PDF December 29, 2015 at 5:02 AM Stephanie and Christopher Smith have been on a long, difficult and often frustrating journey to find answers for the mysterious health issues of their children. It started 24 years ago when their third child, Gage, was born. Gage, his younger brother Aiden and then sister Mandalynn, now […]Continue Reading ...
Download PDF December 2, 2015 at 11:25 AM EKF Diagnostics, the global in vitro diagnostics company, announces that new data has been presented in support of soluble Tumor Necrosis Factor Receptor 1 (sTNFR1) as a biomarker to predict progression of Diabetic Nephropathy (also referred to as Diabetic Kidney Disease). This new data was recently presented […]Continue Reading ...
Download PDF October 18, 2011 at 9:21 AM Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $0.91 in the second quarter of fiscal 2012. Reported earnings per share in the second quarter of fiscal 2011 were $1.00. Net sales for the quarter increased 9.0% to […]Continue Reading ...
Download PDF June 9, 2014 at 6:39 AM Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Actinium’s Clinical Advisory Board Chairman Joseph Jurcic, MD will participate in an upcoming panel discussion highlighting the role of Actinium’s alpha-particle […]Continue Reading ...
Download PDF October 9, 2015 at 3:09 AM The U.S. Food and Drug Administration today approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve blood sugar (glucose) control in adults with diabetes mellitus. According to the Centers for Disease Control and Prevention, approximately 21 million people in the United States […]Continue Reading ...
Download PDF July 22, 2010 at 1:59 AM As consumers overseas embrace foods and beverages made with ingredients long known to have health and wellness benefits, American manufacturers can take a cue from their success and add such medicinal ingredients to their foods and beverages, according to a scientific discussion at the 2010 Institute of […]Continue Reading ...
Download PDF March 1, 2016 at 8:50 AM A specific molecule involved in maintaining pain after a nerve injury has been identified and blocked in mice by Hiroshima University researchers. These results reveal a promising therapeutic strategy for treating neuropathic pain. Mice with an injury to their sciatic nerve showed less pain after multiple injections […]Continue Reading ...
Download PDF October 3, 2014 at 2:15 AM Nonsteroidal anti-inflammatory drugs (NSAIDs) – such as ibuprofen and aspirin – increase one’s risk of upper gastrointestinal bleeding. When taken in combination with other drugs, this risk is significantly higher, according to new research appearing in the October issue of Gastroenterology, the official journal of the American […]Continue Reading ...
Download PDF July 13, 2015 at 2:45 AM Much attention has been paid to genetics in breast cancer as disease rates rise, but most women have no family history of the disease, suggesting that there is an environmental risk we don’t yet understand, says environmental health scientist Laura Vandenberg in the School of Public Health […]Continue Reading ...
Download PDF September 24, 2015 at 8:18 AM Alimera Sciences, Inc., (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN® (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from […]Continue Reading ...
Download PDF January 27, 2006 at 3:40 PM Ever since the advent of recombinant-DNA technology, scientists have conceived that it will be feasible to create entirely new enzymes for specific needs. In an article in the journal Science, researchers from Uppsala and Korea present concrete proof of this. They have succeeded in converting an enzyme […]Continue Reading ...
Download PDF January 17, 2017 at 4:29 AM Seeking to improve the care of preterm infants, a new study by researchers at Rutgers Robert Wood Johnson Medical School has found a more accurate test for jaundice, a common disorder in newborns. Jaundice in preterm infants is caused by the elevation of bilirubin, an orange-yellow substance […]Continue Reading ...
- College students with autism have high rate of suicidal thoughts
- Study sheds light on how the HSC niche is maintained
- Drug test spurs frank talk between hypertension patients and doctors
- Low-cost deworming drug improves female farmers’ physical fitness
- Genome editing identifies neural circuit behind leptin’s anti-obesity and anti-diabetes effects
- Many European countries lack comprehensive policy to eliminate viral hepatitis
- Young people with ADHD ‘more likely’ to come from deprived neighbourhoods
- SLU professor discovers new biomarkers for chlorine gas exposure
- Study proposes new mechanism that may contribute to gender differences in weight control
- Sleep restriction therapy does not interfere with insomnia patient’s driving ability, research shows
- Deep brain stimulation offers relief to UTHealth patient with treatment-resistant depression
- Study shows fatty fish and camelina oil boost HDL and IDL cholesterol
- FDA Alert: Euphoric Capsules by Epic Products: Recall
- Researchers identify peptide produced during cartilage deterioration as a potential source of osteoarthritis pain
- New breakthrough may allow scientists to orchestrate tissue regeneration in humans
- SYGNIS AG introduces new TruePrime apoptotic cell free DNA amplification kit
- Innovative device shows promise in capturing and releasing circulating tumor cells
- Researchers shed light on role of striosomal neurons in reinforcement learning
- Genetic make-up impacts long-term effectiveness of phobia treatment
- Novel biomarker can distinguish malignant lung nodules